Grand Pharma

We are focused on ophthalmology and otorhinolaryngology products, emergency cardiovascular care products, bio-tech and customized API. In recent years, our sales revenue and profit have annually grown over 30% by means of profound strategic transformation, change of the development pattern, acceleration of independent innovation and market expansion. In 2011, we were named one of the China Pharmaceutical Industry Top 100 Enterprises. On the basis of enterprise comprehensive strength, we have been ranked in the 38th place in China Chemical Pharmaceutical Industry in 2015. With continuous introduction of talents, we have a professional sales team (over 1300 employees) and a specialized R&D institution with many international and high-leveled experts and consultants. Well-educated and pragmatic talent reservoir prop us up in innovation and breakthrough, provide opportunities in global competition and reap the benefits of international operation. We have been always insisting on the corporate spirit of advocating pioneering and risk-taking. With our philosophy of offering quality products, honoring code of ethics, we are working on transformation and upgrading so as to keep on enhancing the core business advantages and creating new demand. In virtue of modern management and specialized technology, we are heading towards to corporate modernization and internationalization in order to become a pharmaceutical company respected by Chinese patients and doctors. History